ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies
July 24, 2018Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies, announced today that it has entered into a research collaboration and license agreement with Ge
Pharma Sources Insight January 2025
